Paulson Capital Corp. Announces Meeting Date and Record

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Paulson Capital Corp. Announces Meeting Date and Record Date for the 2013 Annual Meeting of Shareholders

PORTLAND, Ore., Sept. 27, 2013 (GLOBE NEWSWIRE) -- Paulson Capital Corp. (Nasdaq: PLCC ) (the "Company") today announced that its 2013 Annual Meeting of Shareholders will be held on November 8, 2013. Holders of record of the Company's common stock, as reflected on the stock transfer books of the Company, at the close of business on October 11, 2013 (the "Record Date") will be entitled to notice of and to vote at the meeting.

As described in more detail in the Proxy Statement that will be mailed to holders of record of our common stock as of the Record Date, in connection with a proposed restructuring of the Company's business, it is contemplated that an irrevocable liquidating trust (the "Trust") will be created and the holders of record of our common stock as of the Record Date (the "Legacy Shareholders") will be given non-transferable beneficial interests in the Trust in proportion to their pro rata ownership interest in our common stock. It is important to note that (i) unless you are a Legacy Shareholder, you will have no interest in the Trust; and (ii) a Legacy Shareholder will both have an interest in the Trust and own our common stock. Those who become owners of our common stock after the Record Date will own only our stock and will have no rights in the Trust. Anyone interested in purchasing our common stock in order to qualify as a Legacy Shareholder must ensure that the trade settles by the Record Date.

The Trust will hold the majority of the assets currently held by Paulson Investment Company, Inc. ("PIC"), our operating subsidiary through which the business of the Company is currently conducted, and will hold an option to purchase the Company's remaining interest in PIC. It is contemplated that the majority of the assets held by PIC (or the proceeds derived therefrom), currently consisting primarily of underwriter warrants, trading and investment securities, an insurance policy on the life of the founder of the Company, and cash and accounts receivables (the "Trust Assets"), will be liquidated and distributed to the Legacy Shareholders over time, after payment of trust administration expenses including, but not limited to, compensation in connection with stock trading in a manner consistent with past practices of PIC.

The Trust will provide for distribution of sale proceeds to the Legacy Shareholders when a Trust Asset is liquidated. At the time of sale, the Company will have income equal to the sale proceeds received in excess of the Company's basis in the asset and the Company will be liable for any tax due. Any taxes for which the Company is obligated as a result of the liquidation of Trust Assets will be paid by the Trust out of Trust Assets. The distribution of the sale proceeds to the Legacy Shareholder will be a dividend to the Legacy Shareholder at the time of the distribution, creating corresponding tax liability for a dividend received. Because the Trust Assets will be irrevocably placed in trust at a time when the Company could have distributed them as dividends to the Legacy Shareholders under state law, we believe, but cannot guarantee, that the ultimate distribution of the sale proceeds to the Legacy Shareholders should not be restricted if the Company itself would not be permitted to pay a dividend at that time due to state law limitations. If, in fact, the placement of the Trust Assets in the Trust does not overcome the state law restrictions on the payment of dividends, it is possible that the Company may not be able to distribute all or any portion of the sale proceeds when a Trust Asset is liquidated. In that event, the sales proceeds would be retained by the Trust until such time, if any, that the Company is legally permitted to distribute the proceeds as a dividend to the Legacy Shareholders.

About Paulson Capital Corp.

Paulson Capital Corp. is the parent company of Paulson Investment Company, Inc. Headquartered in Portland, Oregon, Paulson Investment Company, Inc. (member FINRA/SIPC) has been a national leader in public offerings of small and emerging growth companies with capital needs of $5 million to $45 million. Founded by Chester "Chet" Paulson in 1970, it has managed or underwritten 166 securities offerings and has generated more than $1.2 billion for client companies. The company's web site is available at www.paulsoninvestment.com .

This release may contain "forward-looking statements" based on current expectations but involving known and unknown risks and uncertainties. Actual results of achievements may be materially different from those expressed or implied. Paulson's plans and objectives are based on judgments with respect to future conditions in the securities markets as well as general assumptions regarding the economy and competitive environment in the securities industry, which can be volatile and out of our control. In particular, we make assumptions about our ability to complete corporate transactions, including the transactions with the Investor Group, which are difficult or impossible to predict accurately and often beyond the control of Paulson. Therefore, there can be no assurance that any forward-looking statement will prove to be accurate.

MEDIA CONTACT: Kellie Davis - Investor Relations 503.243.6000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 7

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 5

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 8

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 12

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding ADHD and the Role of RELEXXII in Treatment

Updated Category News Views 215

Supporting ADHD Awareness: The Role of RELEXXII This month marks a significant time for acknowledging and educating people about Attention Deficit Hyperactivity Disorder (ADHD). Alora Pharmaceuticals, the leading manufacturer behind RELEXXII® (methylphenidate hydrochloride extended-release tablet), is deeply committed to this cause. ADHD impacts various dimensions of...

Continue Reading
New Class Action Filed Against Paragon 28 Over Alleged Fraud

Updated Category News Views 111

Introduction to the New Class Action Against Paragon 28 Hagens Berman has recently taken action by filing a class action lawsuit against Paragon 28, Inc. (NYSE: FNA) alongside several of its senior executives. The case aims to hold the company accountable for alleged fraudulent activities affecting investors. Overview of the Allegations The lawsuit extends an ongoing...

Continue Reading
Subway Teams Up with ARC Raiders for Gaming Promo

Updated Category News Views 16

What’s Cooking Between Subway and Embark Studios? Subway’s diving headfirst into the gaming world, folks. It’s not a piece of cake to see a sandwich giant team up with a game studio, but today, Subway’s sidestepping the typical food deal. Instead, it's sharpening its digital claws with Embark Studios, a Stockholm-based game developer. They’re gearing up for the...

Continue Reading
CagriSema Breakthrough: Weight Loss Success in Adults

Updated Category News Views 312

Significant Weight Loss Achieved with CagriSema in Clinical Trial In recent findings, Novo Nordisk has unveiled compelling results from the extensive REDEFINE 1 trial, focusing on the innovative weight loss treatment, CagriSema. This clinical study assessed the efficacy of subcutaneous CagriSema—a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg—in...

Continue Reading
Endor Labs Achieves Remarkable Growth in Application Security

Updated Category News Views 390

Endor Labs Shows Impressive Revenue Growth Endor Labs, a leader in application security, proudly announces a significant milestone: a whopping 225% year-over-year revenue growth. This achievement highlights the increasing demand for robust security measures that can keep pace with the rapid transformations in software development, especially given the rise of AI...

Continue Reading